Feasibility analysis for the monitoring of COVID-19 vaccines (ACCESS)

For more information on this project, please contact the EU PE&PV research network at eupepv@uu.nl.

Project information

Full title

Feasibility analysis for the monitoring of COVID-19 vaccines (ACCESS)

Principal investigator

Prof. Dr. Miriam Sturkenboom, University Medical Center Utrecht

Participating organisations

  • Utrecht University, The Netherlands - consortium lead
  • UMC Utrecht, The Netherlands - coordinator
  • VAC4EU, Belgium
  • Aarhus University, Denmark
  • BIPS, Germany
  • Université de Bordeaux, France
  • ARS, Italy
  • SoSe Te - Pedianet, Italy
  • University of Messina, Italy
  • Lareb, The Netherlands
  • PHARMO Institute, The Netherlands
  • University of Oslo, Norway
  • AEMPS, Spain
  • FICF, Spain
  • FISABIO, Spain
  • IDIAPJGol, Spain
  • RTI Health Solutions, Spain

Status

Completed (2021)

Deliverables

Peer-reviewed scientific publications

Background rates of 41 adverse events of special interest for COVID-19 vaccines in 10 European healthcare databases - an ACCESS cohort study. Willame C, Dodd C, Durán CE, Elbers R, Gini R, Bartolini C, Paoletti O, Wang L, Ehrenstein V, Kahlert J, Haug U, Schink T, Diez-Domingo J, Mira-Iglesias A, Carreras JJ, Vergara-Hernández C, Giaquinto C, Barbieri E, Stona L, Huerta C, Martín-Pérez M, García-Poza P, de Burgos A, Martínez-González M, Bryant V, Villalobos F, Pallejà-Millán M, Aragón M, Carreras JJ, Souverein P, Thurin NH, Weibel D, Klungel OH, Sturkenboom M. Vaccine. 2023 Jan 4;41(1):251-262. doi: 10.1016/j.vaccine.2022.11.031. Epub 2022 Nov 22. PMID: 36446653; PMCID: PMC9678835.